NRx Pharmaceuticals Produces First Phase 3-stage NRX-101 Drug Made Using Commercial Process
- Wednesday, November 9, 2022, 7:04
- Finance
- Add a comment
Manufacturing files submitted to U.S. Food and Drug Administration The company has now completed its transition to U.S.-based manufacturing NRX-101 is now manufactured via a commercial-stage process RADNOR, Pa., Nov. 9, 2022 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), (“NRx…
About the Author
adminasapcorp has written 41790 stories on this site.